Quantum Biopharma (QNTM) Long-Term Investments (2018 - 2025)

Quantum Biopharma's Long-Term Investments history runs 8 years deep, the most recent figure standing at $2224.0 for Q1 2025.

• In Q1 2025, Long-Term Investments changed N/A year-over-year to $2224.0; the TTM figure through Mar 2025 stood at $2224.0 (changed N/A YoY), while the FY2024 annual figure was $2224.0, down 63.23% from the prior year.
• Long-Term Investments came in at $2224.0 for Q1 2025 at Quantum Biopharma, roughly flat from $2224.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $827612.0 in Q4 2022 to a low of $2224.0 in Q4 2024.
• A 5-year average of $250710.2 and a median of $5987.5 in 2023 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments increased 25.35% in 2022 and tumbled 99.27% in 2023, its largest moves.
• Quantum Biopharma's Long-Term Investments stood at $660226.0 in 2021, then increased by 25.35% to $827612.0 in 2022, then sank by 99.27% to $6049.0 in 2023, then tumbled by 63.23% to $2224.0 in 2024, then changed by 0.0% to $2224.0 in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $2224.0, $2224.0, and $5926.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison